Cargando…
Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy
Autores principales: | Huo, Shufan, Ferse, Caroline, Bösl, Fabian, Reincke, S. Momsen, Enghard, Philipp, Hinrichs, Carl, Treskatsch, Sascha, Angermair, Stefan, Eckardt, Kai-Uwe, Audebert, Heinrich J., Ploner, Christoph J., Endres, Matthias, Prüss, Harald, Franke, Christiana, Scheibe, Franziska |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089297/ https://www.ncbi.nlm.nih.gov/pubmed/35538168 http://dx.doi.org/10.1007/s00415-022-11152-5 |
Ejemplares similares
-
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
por: Franke, Christiana, et al.
Publicado: (2021) -
Brain antibody sequence evaluation (BASE): an easy-to-use software for complete data analysis in single cell immunoglobulin cloning
por: Reincke, S. Momsen, et al.
Publicado: (2020) -
A Neurological Outpatient Clinic for Patients With Post-COVID-19 Syndrome — A Report on the Clinical Presentations of the First 100 Patients
por: Boesl, Fabian, et al.
Publicado: (2021) -
Do cross-reactive antibodies cause neuropathology in COVID-19?
por: Kreye, Jakob, et al.
Publicado: (2020) -
Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics
por: Ly, Lam-Thanh, et al.
Publicado: (2018)